---
review_id: idea-evaluation-I01-001-v057-r001
reviewer_skill: idea-evaluator
reviewer_instance_id: old-v057-fresh-evaluator-001
workflow_id: RID-SEPSIS-CSM-20260717-001
round_id: r001
idea_id: I01-001
input_artifact_ids:
  - idea-dossier-I01-001-v057
input_versions:
  - v057
files_read:
  - tests/idea-narrative-forward-0.9.0-preview.3/one-pass-current/direct-final-current-v23/idea-dossier-v057.md
review_scope: complete_idea_dossier
isolation_mode: fresh_subagent
prior_scores_visible: false
prior_versions_visible: false
revision_delta_visible: false
source_edits_performed: false
reviewed_dossier_ref:
  artifact_id: idea-dossier-I01-001-v057
  version: v057
  path: tests/idea-narrative-forward-0.9.0-preview.3/one-pass-current/direct-final-current-v23/idea-dossier-v057.md
complete_dossier_confirmed: true
dossier_only_input_confirmed: true
identity_drift_detected: false
historical_identity_drift_assessed: false
evaluation_frozen_before_journal_search: true
evaluation_changed_after_journal_search: false
---

# Idea Evaluation Report

- **Reviewer instance ID:** old-v057-fresh-evaluator-001
- **Review ID / workflow ID / round ID:** idea-evaluation-I01-001-v057-r001 / RID-SEPSIS-CSM-20260717-001 / r001
- **Input artifact ID / version:** idea-dossier-I01-001-v057 / v057
- **Idea ID / title:** I01-001 / 用于描述重症监护期间脓毒症发病前风险、首次发病、发病后状态及其转移的候选动态表征：24 个月阶段 I–II 构建与计划跨数据库检验
- **Current dossier logical reference:** `idea-dossier-I01-001-v057`, `v057`, `tests/idea-narrative-forward-0.9.0-preview.3/one-pass-current/direct-final-current-v23/idea-dossier-v057.md`
- **Files read:** `tests/idea-narrative-forward-0.9.0-preview.3/one-pass-current/direct-final-current-v23/idea-dossier-v057.md`
- **Isolation mode:** `fresh_subagent`
- **Complete dossier confirmed:** true
- **Dossier-only input confirmed:** true
- **Identity drift detected:** false
- **Historical identity drift assessed:** false
- **Prior scores / prior versions / revision delta visible:** false / false / false
- **Source edits performed:** false
- **Evaluation frozen before journal search:** true
- **Evaluation changed after journal search:** false

## Frozen dossier-only evaluation

The evaluation in this section was completed and frozen before any journal search. The later journal-matching phase did not alter it.

### Structural, logical-reference, and identity checks

- The frontmatter declares `schema_version: research-idea.v3`, artifact ID `idea-dossier-I01-001-v057`, version `v057`, and the exact reviewed path; those values resolve consistently within the dossier.
- The H1 title and the `Title` field are identical. All 15 required sections are present in the required order, section 3 contains the five required reasoning subsections in order, and the dossier contains references, five evidence chains, and a five-row Claim-Support table.
- The body remains consistent with the current identity anchor: the central object is the longitudinal sepsis-centered ICU system, the primary inference unit is patient-time state and transition, the public ICU databases remain the core evidence base, and the randomized-trial work remains conditional and subordinate. No repair identified below requires replacing an identity anchor.
- Historical identity drift was not assessed because prior versions were unavailable by design.

### Evidence-chain checks

| Chain title | Input sufficiency | Transformation validity | Output relevance | Objective/hypothesis traceability | Closure |
|---|---|---|---|---|---|
| 可用性时钟、风险集与互斥病程 | **Pass.** The dossier names the label ingredients, time stamps, outcomes, database dictionaries, and the planned support audit. | **Pass.** The dual-clock, landmark, competing-event, delayed-entry, weighting, and leakage checks are mutually consistent with the two clinical tasks. | **Pass.** The risk-set, multistate cohort, label-difference table, and leakage record are directly usable outputs. | **Pass.** The output directly supports objective 1 and the stated pre-onset-to-outcome boundary. | **Closed.** Every output has a named input and transformation; empirical support remains a planned result rather than a hidden premise. |
| 双库支持、锚定与绝对恢复 | **Conditional pass.** Required inputs are specified, but the common anchors, interfaces, event support, access, and project counts remain unaudited. | **Pass.** Complexity locking, anchoring, simulation scenarios, absolute recovery, zero-edge, and misspecification checks form a valid staged route with prespecified fallbacks. | **Pass.** The output is either a qualified complex representation or a simpler retained representation with object-level non-promotion records. | **Pass.** It directly tests objectives 2 and 3 and the recoverable-invariant portion of the core hypothesis. | **Conditionally closed.** The chain closes logically, but only after the month-3/month-6 resource and support gates are satisfied. |
| 两项主要任务与两项次要表征诊断 | **Pass.** Fixed cohorts, states, eligible models, validation splits, and metrics are named. | **Pass.** The two primary estimands, proper scores, calibration, clustered uncertainty, secondary diagnostics, ablations, and negative controls are role-consistent. | **Pass.** The planned scores, calibration, state probabilities, coverage, and stratified failure figures are relevant to the phase-II decision. | **Pass.** It directly supports objective 3 and the conjunctive phase-II success definition. | **Closed.** The dossier prevents secondary diagnostics from rescuing failed primary tasks. |
| 医院优先的计划跨数据库检验 | **Conditional pass.** The frozen-development record, eICU hospital split, patient-link audit, common anchors, and thresholds are specified but not yet generated. | **Pass.** Hospital-first allocation, cross-partition exclusion, graph sensitivity analysis, frozen external validation, and distinct adaptation operations preserve the intended evidence hierarchy. | **Pass.** The outputs distinguish primary external evidence, adaptation, refitting, support loss, and stopped interpretations. | **Pass.** It directly supports objective 3 and the cross-database component of the core hypothesis. | **Conditionally closed.** Closure depends on maintaining test-set isolation and minimum hospital/event/anchor support. |
| 有前置条件的随机试验次要分析 | **Conditional pass.** Individual-level access, original trial materials, visit timing, center/randomization semantics, and common-anchor eligibility remain unverified. | **Qualified pass.** The detailed methods define mapping-qualified, independent-SOFA, and stop branches, but the chain summary compresses them into the generic phrase “预设的实际访视有序结局分析.” | **Pass.** A trial-specific secondary result or a documented reason not to analyze is relevant to objective 4. | **Pass.** It remains subordinate to phase II and does not claim to validate latent dynamics or causal mechanisms. | **Conditionally closed.** The method section closes the branches, but the evidence-chain row should make those alternative outputs explicit. |

### Title and positioning Claim-Support checks

| Claim | Registration complete | Implementation/output support | Actual increment accurate | Claim scope precise | Positioning scope supported |
|---|---|---|---|---|---|
| 候选动态表征覆盖发病前风险、首次发病、发病后状态及其转移 | **Pass.** Frame, implementation, chains, literature basis, increment, and status are all registered. | **Pass.** The dual-clock cohort and anchoring/recovery chains support the planned object. | **Pass.** The increment is integration of the full-course input, constrained transformation, and auditable output. | **Pass.** “候选” and “计划” remain in the title and summary. | **Pass.** The dossier does not convert this into a validated or causal-system claim. |
| 24 个月阶段 I–II 构建与计划跨数据库检验 | **Pass.** All required Claim-Support columns are populated. | **Pass, conditional on resources.** The hospital-first split, isolation, freezing, and external-validation chain support the planned action. | **Pass.** Isolation, patient separation, and negative-result recording are identifiable increments in the validation route. | **Pass.** The claim is explicitly prospective and conditional. | **Pass.** Access, audit, and results are disclosed as incomplete. |
| 主体研究达标后按试验分别开展次要分析 | **Pass.** The conditional role and evidence source are registered. | **Pass, conditional.** The methods provide mapping, independent-SOFA, and stop branches for each trial. | **Pass.** The increment is a subordinate, trial-specific visit-outcome analysis rather than a claim of system perturbation validation. | **Pass.** It is not presented as a parallel primary contribution. | **Pass.** The dossier repeatedly prevents trial results from repairing phase-II failure. |
| 贡献是整合、验证和基准或研究资源 | **Pass.** The claim is fully registered. | **Pass.** The first four chains jointly support the input/transformation/output integration. | **Pass.** The dossier does not claim a new algorithm and identifies a conditional combination increment. | **Pass.** The resource and validation value is phrased prospectively. | **Pass.** This is the strongest defensible contribution frame on the represented evidence. |
| 有界检索尚未建立完整组合的代表性先例 | **Pass.** The limitation and no-nonexistence qualifier are explicit. | **Qualified pass.** The closest-work table and dossier citations support only a bounded comparison. | **Pass.** It explicitly states that no scientific or method novelty is claimed from this row. | **Pass.** “低至中等置信” and “不等于先例不存在” preserve the boundary. | **Pass, qualified.** It cannot support a stronger first-in-field claim without a broader search. |

### Scores and gates

| Dimension | Score | Dossier-located rationale |
|---|---:|---|
| Novelty | 4 | In **“Contribution, innovation, impact, application, and closest-work comparison”**, the dossier distinguishes existing modules from a conditional integration/validation increment and does not inflate that increment into a new-algorithm or first-in-field claim. The bounded search limitation prevents a 5. |
| Feasibility | 3 | **“Feasibility and resources,” “Current resource and result status,”** and **“Risks, alternatives, and stop conditions”** provide strong staging, complexity caps, stop rules, and fallback routes. However, database access, executable extracts, actual support counts, named personnel, common anchors, and several specifications remain unverified, while the 24-month route is capacity-intensive. |
| Impact | 4 | **“Contribution and evidence ladder”** and **“Planned outputs”** support meaningful benchmark, validation, reusable-resource, and methodological-governance value if executed. The dossier correctly withholds clinical-effectiveness, causal, control, and digital-twin claims, so the impact is strong but bounded. |
| Relevance | 4 | **“Title, summary, audience, and positioning”** and **“Research question, objectives, and core hypothesis”** align the question, outputs, audience, 24-month phase-I–II boundary, and high-level publication aim. Relevance is assessed only against goals represented in the dossier because no separate user brief was available. |
| Clarity | 4 | **“Background, current state, gap, significance, and rationale”** performs the five functions in the required order and leads intelligibly to the dual-clock and validation design. Definitions are generally introduced before use. The primary question and later technical sections remain dense, and the conditional trial extension increases terminology and branch-tracking burden. |
| Completion | 4 | The dossier contains all 15 substantive sections, resolved internal references, five evidence chains, a complete Claim-Support table, analyses, outputs, falsification rules, limitations, assumptions, and stop conditions. Completion falls short of 5 because the trial chain summary hides its three outcome branches and several core feasibility inputs remain explicitly unresolved. |

- **Simple unweighted mean:** 3.83
- **Fatal flaws:** none
- **Decision:** `revise_then_promote`

#### Hard gates

| Gate | Result | Dossier-located rationale |
|---|---|---|
| Feasibility | pass | Score 3. The staged route and fallbacks in **“24 个月最低交付与时间节点”** and **“Risks, alternatives, and stop conditions”** make the work defensible, but promotion should wait for bounded resource/capacity documentation. |
| Relevance | pass | Score 4. The question, audience, contribution frame, outputs, and 24-month boundary align in **“Title, summary, audience, and positioning”** and **“Research question, objectives, and core hypothesis.”** |
| Clarity | pass | Score 4. The ordered reasoning chain in section 3 is distinct and intelligible, and no gap-to-rationale or significance failure is present. |
| Completion | pass | Score 4. The complete 15-section dossier, closed or explicitly conditional chains, references, Claim-Support table, and stop logic meet the dossier contract. |

### Findings

| Title | Dossier locator | Severity | Rationale |
|---|---|---|---|
| The contribution is honestly bounded and distinguishable | **Contribution and evidence ladder; Verified representative closest-work comparison; Title and positioning claim-support table** | Strength | The dossier identifies integration, validation, benchmark/resource, and governance value while explicitly declining a new-algorithm, causal-system, digital-twin, or global-first claim. This supports a strong Novelty score without relying on prose quality. |
| Core execution resources remain unverified | **Data, materials, and existing evidence base → Current resource and result status; Feasibility and resources** | Major | Team access credentials, agreements, executable extraction, project-specific counts, common anchors, named personnel, and available effort are not yet confirmed. These are genuine dependencies for every major phase-II work package. |
| The 24-month minimum route lacks a capacity budget | **Research content and work packages → 24 个月最低交付与时间节点; Feasibility and resources** | Moderate | The plan combines two database builds, label engineering, several baselines, at least 1,000 simulation repetitions per core scenario, model qualification, primary tasks, test-set governance, and external validation, but it does not map personnel effort, compute demand, or critical-path slack to the monthly milestones. |
| The conditional trial evidence chain is over-compressed | **Evidence chain: 有前置条件的随机试验次要分析; Research design and methods → 试验观测映射和独立分析** | Moderate | The detailed method has three materially different outcomes—mapping-qualified ordered outcome, independent SOFA outcome, or no new visit-outcome analysis—whereas the chain summary names only a generic prespecified visit analysis. The method is defensible, but chain-level closure is harder to audit. |
| The combined-gap evidence remains deliberately limited | **Verified representative closest-work comparison; Limitations and boundary conditions item 9** | Moderate | The dossier itself states that the search is bounded rather than systematic and gives only low-to-moderate confidence to the complete-combination gap. The current integration/validation frame is supportable; stronger novelty language would not be. |
| The primary question carries the subordinate extension | **Research question, objectives, and core hypothesis → Primary research question** | Minor | A single long question combines the phase-I–II dynamic-representation study with the conditional post-phase-II trial extension. The identity remains consistent, but target readers must hold a secondary branch before the main hypothesis is fully established. |

### Repair directions

1. In the dossier's feasibility authority, add a compact capacity-and-readiness record for the 24-month phase-I–II route: named or explicitly vacant roles, estimated effort by milestone, computing and storage assumptions, access/extraction evidence status, critical-path dependencies, and the consequence when capacity is below the minimum. Preserve the existing identity and stop rules.
2. Before promotion, update the current resource table with the outcome of the month-3 access/personnel checks or, if they are still pending, state the exact pre-start evidence required to authorize each major work package; do not treat public database existence as executable access.
3. Expand the **“有前置条件的随机试验次要分析”** evidence chain so its transformation and output explicitly register the mapping-qualified branch, independent-SOFA fallback, and core-semantics stop branch, with each branch tied to objective 4. Do not add a new primary contribution.
4. Keep the current conditional integration/validation positioning unless a broader, reproducible closest-work search supports a stronger claim. If that search is not performed, preserve the present low-to-moderate-confidence qualifier everywhere.
5. Reduce branch-tracking burden in the reader-understanding core by presenting the trial extension as a clearly subordinate secondary question while preserving the identity anchor and the existing scientific content.

### Limitations

- This was a dossier-only review. No reference, dataset, local report, prior dossier, delta, state file, or prior evaluation was opened, and no claim was upgraded from memory.
- Literature and resource statements were judged only as represented and qualified inside the dossier; their external truth was not checked during scoring.
- Relevance was evaluated against the goals and constraints stated inside the dossier because no separate user brief was an allowed input.
- Historical identity drift was not assessed.

### Unresolved issues

- Whether two role-appropriate ICU databases are accessible and executable by month 3, and whether a backup can satisfy the same audit.
- Whether project-specific events, transitions, hospitals, cross-hospital patients, interfaces, and common physiological anchors meet the month-6 support thresholds.
- Whether the required clinical, statistical, system-identification, data-engineering, implementation, and independent-custodian roles receive named commitments and sufficient effort.
- Whether the four registered working assumptions are resolved at their prespecified decision points without access to isolated-test results.
- Whether trial-level authorization and original randomization, center, visit, and outcome semantics are available for either conditional secondary analysis.
- Whether a broader closest-work search changes the current low-to-moderate-confidence combination-gap statement.

## Post-evaluation journal matching

This phase began only after the preceding evaluation was frozen. The matching is advisory, score-free, unranked, and based only on official scope and article-type information. It did not change any score, gate, fatal flaw, decision, finding, repair direction, limitation, or unresolved scientific issue.

```yaml
evaluation_frozen_before_journal_search: true
evaluation_changed_after_journal_search: false
external_urls_consulted:
  - source_id: J01
    url: https://www.nature.com/npjdigitalmed/aims
    publisher_or_journal: npj Digital Medicine / Springer Nature
    page_type: aims_and_scope
    source_status: usable
    checked_at: 2026-07-20
  - source_id: J02
    url: https://www.nature.com/npjdigitalmed/content-types
    publisher_or_journal: npj Digital Medicine / Springer Nature
    page_type: article_types
    source_status: usable
    checked_at: 2026-07-20
  - source_id: J03
    url: https://link.springer.com/journal/13054/aims-and-scope
    publisher_or_journal: Critical Care / Springer Nature
    page_type: aims_and_scope
    source_status: usable
    checked_at: 2026-07-20
  - source_id: J04
    url: https://link.springer.com/journal/13054/submission-guidelines
    publisher_or_journal: Critical Care / Springer Nature
    page_type: instructions_for_authors
    source_status: discarded_disallowed_content
    checked_at: 2026-07-20
  - source_id: J05
    url: https://link.springer.com/journal/13054/submission-guidelines/research
    publisher_or_journal: Critical Care / Springer Nature
    page_type: article_types
    source_status: usable
    checked_at: 2026-07-20
  - source_id: J06
    url: https://academic.oup.com/jamia/pages/General_Instructions
    publisher_or_journal: Journal of the American Medical Informatics Association / Oxford University Press
    page_type: instructions_for_authors
    source_status: discarded_disallowed_content
    checked_at: 2026-07-20
journal_matching:
  status: completed
  match_basis: official_scope_and_article_type_only
  candidate_brief:
    schema_version: research-idea-journal-candidate-brief.v1
    brief_id: journal-candidate-brief-I01-001-v057-r001
    matching_source_skill: idea-evaluator
    source_dossier_ref:
      artifact_id: idea-dossier-I01-001-v057
      version: v057
      path: tests/idea-narrative-forward-0.9.0-preview.3/one-pass-current/direct-final-current-v23/idea-dossier-v057.md
    evaluation_fields_included: false
    scoring_present: false
    ranking_present: false
    publication_probability_present: false
    candidates:
      - candidate_id: C01
        publication_unit:
          unit_id: stage_II_dynamic_representation_validation
          dossier_locator: "Expected outputs, falsification criteria, and interpretations → Planned outputs, items 1–4; Evidence chain: 医院优先的计划跨数据库检验"
          whole_idea_reason: null
        journal_title: npj Digital Medicine
        proposed_article_type: Article
        scope_fit: "The official scope includes innovative artificial intelligence and informatics, clinical application of novel or validated AI and machine-learning models, digital twins, and validated digital biomarkers. A completed stage-II paper centered on a constrained dynamic representation, rigorous cross-database validation, and auditable model governance falls within that digital-medicine territory."
        article_type_fit: "The official content-type page defines an Article as substantial original primary research; the planned stage-II empirical study could use this type after results are generated."
        mismatch_risks:
          - "The official scope says the journal typically does not consider purely observational studies. The manuscript would need to demonstrate that its original validated digital-model contribution is more than a retrospective observational analysis."
          - "The dossier does not yet contain results, and the journal's Article type requires substantial completed primary research."
          - "The dossier explicitly declines a current digital-twin and clinical-tool claim, so the match should rest on validated informatics and cross-database evidence rather than digital-twin rhetoric."
        official_source_ids:
          - J01
          - J02
      - candidate_id: C02
        publication_unit:
          unit_id: clinical_tasks_and_frozen_external_validation
          dossier_locator: "Evidence chain: 两项主要任务与两项次要表征诊断; Evidence chain: 医院优先的计划跨数据库检验; Expected outputs, items 1–4"
          whole_idea_reason: null
        journal_title: Critical Care
        proposed_article_type: Research
        scope_fit: "The official scope centers evidence relevant to intensivists and the care of critically ill patients. A completed sepsis-focused paper on onset risk, post-onset states, calibration, negative results, and hospital-level external validation is directly relevant to that audience."
        article_type_fit: "The official Research instructions explicitly accommodate observational studies through STROBE and require completed methods, results, implications, and limitations; this matches a completed retrospective multi-database validation paper."
        mismatch_risks:
          - "A manuscript dominated by latent-state mathematics or software architecture could be less aligned than one organized around clinically interpretable sepsis tasks and critical-care implications."
          - "The phase-III trial analyses should remain separate unless they form a coherent completed publication unit; they are not needed for this stage-II match."
          - "The match depends on generated external-validation results and a clear explanation of how the evidence matters to intensivists; a protocol-only dossier is not yet the proposed Research article."
        official_source_ids:
          - J03
          - J05
    no_candidate_reason: null
  unresolved_issues:
    - "The final number and boundaries of publication units depend on completed stage-II outputs; the dossier currently allows one or more papers."
    - "No journal metrics, rankings, acceptance rates, or publication probabilities were used."
    - "J04 and J06 were discarded because the opened pages exposed disallowed non-scope/article-type material; no candidate relies on them."
```

### Candidate-match reading notes

- **npj Digital Medicine:** its official scope explicitly covers AI/informatics and digital models, while also warning that purely observational work is typically outside scope. The candidate is therefore defensible only for a completed, substantial validation paper whose contribution is the digital-model and cross-database evidence, not for a protocol or an inflated digital-twin claim. Official support: [aims and scope](https://www.nature.com/npjdigitalmed/aims) and [content types](https://www.nature.com/npjdigitalmed/content-types).
- **Critical Care:** its official scope is directly tied to evidence for intensivists, and its Research instructions accommodate observational studies. The most defensible unit foregrounds the two clinical tasks, clinically interpretable post-onset states, and frozen cross-database validation. Official support: [aims and scope](https://link.springer.com/journal/13054/aims-and-scope) and [Research article instructions](https://link.springer.com/journal/13054/submission-guidelines/research).

Candidate order is not a ranking. No separate candidate YAML or medical-journal review was created.
